Drug-Eluting Balloons

This channel includes news and new technology innovations for drug coated balloons, also referred to as drug-eluting balloons. These are used to treat peripheral and coronary artery lesions and restenosis.

Medtronic, CE Mark, IN.PACT Admiral DEB, arteriovenous AV access, hemodialysis, end-stage renal disease patients
News | Drug-Eluting Balloons | January 18, 2016

January 18, 2016 — Medtronic plc announced that the IN.PACT Admiral ...

ISAR-DESIRE 4 trial, TCT 2015, drug-coated balloon, DCB, scoring balloon, SCB, drug-eluting stent restenosis

Image courtesy of Medtronic

Feature | Drug-Eluting Balloons | October 22, 2015

October 22, 2015 — Results from the ISAR-DESIRE 4 trial indicate that use of a scoring balloon plus a...

IN.PACT SFA study, TCT 2015, drug-coated balloons, PTA, SFA disease, superficial femoral artery

Image courtesy of Medtronic

Feature | Peripheral Artery Disease (PAD) | October 18, 2015

October 18, 2015 — Two-year results from the IN.PACT SFA study found the use of a...

Lutonix Global Real-World Registry results, TCT 2015, Lutonix 035 DCB, peripheral arterial disease, PAD

Image courtesy of C.R. Bard

News | Drug-Eluting Balloons | October 15, 2015

October 15, 2015 — C. R. Bard Inc. announced the presentation of the 12-month results from the Lutonix Global Real-...

News | Cath Lab | August 26, 2015

August 26, 2014 — The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report...

C.R. Bard, LEVANT 2 results, Lutonix 035 DCB, drug coated balloon, PTA
Feature | Drug-Eluting Balloons | July 08, 2015

July 8, 2015 - C.R. Bard Inc. announced the publication of results from the LEVANT 2 study in the June 24, 2015,...

Lutonix DCB, CMS, reimbursement, pass-through payment, outpatient use
News | Drug-Eluting Balloons | June 11, 2015

June 11, 2015 - C.R. Bard Inc. announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has improved...

IN.PACT Admiral, Global Study, DEB SFA-LONG, long peripheral lesions, EuroPCR
News | May 22, 2015

May 22, 2015 — New clinical data from two different studies...

Stellarex, Spectranetics, investment, BTK, peripheral artery disease
News | May 06, 2015

May 6, 2015 — The Spectranetics Corporation announced it is accelerating investments in the Stellarex...

Videos | Drug-Eluting Balloons | April 02, 2015

In 2015, the FDA approved the first two drug-coated balloons for the U.S. market to treat peripheral artery disease...

Videos | Cath Lab | March 25, 2015

Hear the latest trends and news on interventional cardiology from the American College of Cardiology (ACC) 2015...

Biotronik, Passeo-18 Lux, DCB, BIOLUX P-I, trial, drug eluting, balloon catheter
News | March 04, 2015

March 4, 2015 — Biotronik announced that results of its BIOLUX P-I...

In.PACT Admiral, PAD, Medicare, pass-through payment, Medtronic, balloon cath
News | February 23, 2015

February 23, 2015 — Medtronic announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved...

Bard, Lutonix, drug coated balloon, DCB, CMS, pass-through payment, outpatient
News | February 23, 2015

February 23, 2015 — C. R. Bard Inc. announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has...

Lutonix, drug eluting balloon, drug coated balloon

The Bard Lutonix drug-eluting balloon was the first DEB to gain FDA approval in October 2014. Illustration by Mike Austin. Copyright 2015. All Rights Reserved.

Feature | February 19, 2015 | Dave Fornell

Drug-eluting balloons (DEBs), also referred to as drug-coated balloons (DCBs), have been one of the long-awaited new...

Overlay Init